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Summary
 
To seek information on the role of Fas in negative selection, we examined subsets of thy-
mocytes from normal neonatal mice versus Fas-deficient 
 
lpr/lpr
 
 mice injected with graded doses
of antigen. In normal mice, injection of 1–100 
 
m
 
g of staphylococcal enterotoxin B (SEB) in-
duced clonal elimination of SEB-reactive V
 
b
 
8
 
1
 
 cells at the level of the semi-mature population
of HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 cells found in the thymic medulla; deletion of CD4
 
1
 
 8
 
1
 
 cells was minimal.
SEB injection also caused marked elimination of V
 
b
 
8
 
1
 
 HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 thymocytes in 
 
lpr/lpr
 
mice. Paradoxically, however, elimination of these cells in 
 
lpr/lpr
 
 mice was induced by low-to-
moderate doses of SEB (
 
#
 
1 
 
m
 
g) but not by high doses (100 
 
m
 
g). Similar findings applied when
T cell receptor transgenic mice were injected with specific peptide. These findings suggest that
clonal elimination of semi-mature medullary T cells is Fas independent at low doses of antigen
but Fas dependent at high doses. Previous reports documenting that negative selection is not
obviously impaired in 
 
lpr/lpr
 
 mice could thus reflect that the antigens studied were expressed at
only a low level.
 
S
 
elf-tolerance induction is largely a reflection of negative
selection (clonal deletion) of immature T cells during
maturation in the thymus (1–4). Despite the importance of
central (thymic) tolerance, some self-antigens, e.g., tissue-
specific antigens, are poorly represented in the thymus.
Hence, unresponsiveness of T cells to these antigens is
thought to involve peripheral mechanisms. Of the various
mechanisms proposed to account for peripheral tolerance,
considerable attention has been focused on the role of Fas
(CD95) (5–8). This cell-surface molecule is upregulated af-
ter TCR stimulation and results in activation-induced cell
death (AICD)
 
1
 
 through interaction with Fas ligand during
the late stages of the primary response. In support of this
view, the normal elimination of T cells after the primary
response (9–11) is impaired in Fas-deficient 
 
lpr/lpr
 
 mice
(11–16).
During later life 
 
lpr/lpr
 
 mice develop massive lymphade-
nopathy and auto-antibody production (17). This syn-
drome is considered to reflect a breakdown of peripheral
tolerance as the result of defective AICD (8, 11–17). The
possibility that 
 
lpr/lpr
 
 mice have a defect in central toler-
ance seems unlikely since most groups have failed to find
evidence for impaired negative selection in the thymus of
 
lpr/lpr
 
 mice (11, 12, 17–25). Nevertheless, a recent study
found reduced apoptosis of cortical thymocytes in 
 
lpr/lpr
 
mice after injection of specific peptides or anti-TCR mAb
(26). However, this effect was only apparent within the
first 24 h after injection.
Most studies on thymic tolerance have focused on nega-
tive selection occurring in the cortex. Recently, we ob-
tained evidence that negative selection can operate at the
level of the semi-mature subset of heat-stable antigen
(HSA)
 
hi
 
 CD4
 
1
 
 8
 
2
 
 cells found in the medulla (27). Thus,
combined TCR/CD28 ligation in vitro induced rapid
(
 
,
 
24 h) induction of apoptosis in HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 cells; by
contrast, for fully mature HSA
 
lo
 
 CD4
 
1
 
 8
 
2
 
 thymocytes
TCR/CD28 ligation caused T cell activation rather than
death. An unexpected finding in these experiments was
that Fas played a decisive role in TCR/CD28-mediated
apoptosis, but only when TCR ligation was induced with a
high concentration of anti-TCR mAb. With a low-to-
moderate concentration of this mAb, apoptosis induction
was Fas-independent. Therefore, the implication is that Fas
expression might play an important role in negative selec-
tion, but only for antigens expressed at a high level.
Since the above data were derived from a highly artificial
in vitro model, the relevance of the data to normal negative
selection in vivo is questionable. To seek direct evidence
on the possible role of Fas in negative selection, we have
now examined the effects of injecting normal versus 
 
lpr/lpr
 
mice with various doses of Staphylococcus enterotoxin B
(SEB), a soluble superantigen (SAg) recognized by V
 
b
 
8
 
1
 
1
 
Abbreviations used in this paper:
 
 AICD, activation-induced cell death;
BrdU, bromodeoxyuridine; DP, double positive; guinea pig C, guinea
pig complement; HSA, heat-stable antigen; ova, ovalbumin; SEB, staphy-
lococcal enterotoxin B; SP, single positive; TUNEL, TdT-mediated
dUTP-biotin nick end labeling.
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CD4
 
1
 
 T cells (28); previous studies have shown that injec-
tion of this antigen induces clonal elimination of T cells in
the thymus (29). We also examined negative selection in
D011 TCR transgenic mice (30) after injection of specific
ovalbumin (ova) peptide. In each situation, injection of an-
tigen caused elimination of HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 thymocytes.
However, in 
 
lpr/lpr
 
 mice, negative selection failed to occur
when the dose of antigen was raised to a high level.
 
Materials and Methods
 
Mice.
 
C3H/HeJ (C3H), MRL/Mpr-Fas
 
lpr
 
 (MRL
 
lpr/lpr
 
), C3H.
MRL-Fas
 
lpr
 
 (C3H
 
lpr/lpr
 
), C57BL/6J (B6), and B6-Fas
 
lpr
 
 (B6
 
lpr/lpr
 
) mice
were purchased from The Jackson Laboratory (Bar Harbor, ME) and
maintained in our animal facility. D011 TCR transgenic mice (30)
were bred in our facility and backcrossed three times to MRL
 
lpr/lpr
 
;
when used in experiments, neonatal mice were typed individually
for Fas and TCR clonotype expression using specific mAbs.
 
Antibodies.
 
Antibodies specific for the following markers have
been previously described (30, 31): CD4 (RL172, rat IgM), CD8
(3.163.8, rat IgM), CD25 (7D4, rat IgM), HSA (J11D, rat IgM),
Thy 1.2 (J1j, rat IgM), D011 TCR (KJ1-26, mouse IgG), TCR
V
 
b
 
8 (F23.1, mouse IgG), and class II (M5/114, rat IgG). Purified
mAbs from ascites specific for TCR-
 
b
 
 (H57-597, hamster IgG;
reference 32) and CD28 (37.51, hamster IgG; reference 33) were
used for stimulation of cells. FITC-conjugated anti-CD4 (H129.19,
rat IgG) and PE-conjugated anti-CD8 (53-6.7, rat IgG) mAbs were
purchased from GIBCO BRL (Gaithersburg, MD). The following
mAbs were purchased from PharMingen (San Diego, CA): FITC-
conjugated mAbs specific for HSA (M1/69, rat IgG); PE- or bi-
otin-conjugated mAbs specific for TCR V
 
b
 
8.1,2 (MR5-2, rat
IgG) and V
 
b
 
6 (RR4-7, rat IgG); and Cy-chrome–conjugated
anti-CD4 (H129.19). FITC-conjugated anti-bromodeoxyuridine
(BrdU) (B44, mouse IgG) mAb was purchased from Becton Dick-
inson (San Jose, CA). Cy5 conjugation to mAbs was performed
using the Fluoro Link-Ab Cy5 Labeling Kit (Amersham Corp.,
Arlington Heights, IL).
 
Ova Peptide.
 
Ova 323–339 peptides (ISQAVHAAHAEIN-
EAGR) were synthesized on a synthesizer (model 431A; Applied
Biosystems, Foster City, CA) by standard solid phase peptide syn-
thesis method (tBoc chemistry) and purified with C18 reverse-
phase HPLC. The concentration of peptides was determined by
quantitative amino acid analysis.
 
Cell Purification.
 
Purification of HSA
 
hi
 
 or HSA
 
lo
 
 CD4
 
1
 
 8
 
2
 
thymocytes was performed as previously described (27). In brief,
for purification of HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 cells, thymocytes were treated
with mAbs specific for CD8 (3.168.8) and CD25 (7D4) plus
guinea pig complement (C) for 45 min at 37
 
8
 
C, positively
panned with anti-CD4 (RL172) mAb, then positively panned
with anti-HSA (J11d) mAb; panning was performed at 4
 
8
 
C.
HSA
 
lo
 
 CD4
 
1
 
 8
 
2
 
 cells were purified by treating thymocytes with
mAbs specific for HSA, CD8, and CD25 plus guinea pig C at
37
 
8
 
C followed by positive panning with anti-CD4 mAb. CD8
 
2
 
thymocytes were purified by negative panning with anti-CD8
mAb. Control experiments established that the procedures used
for purifying thymocyte subsets did not alter the sensitivity of the
cells to TCR-mediated apoptosis (27). Splenic APCs were puri-
fied by treating spleen cells with mAbs specific for Thy 1.2 (J1j),
CD4 (RL172), CD8 (3.168.8) and HSA (J11D) plus guinea pig C
for 45 min at 37
 
8
 
C.
 
In Vivo Treatment for the Deletion of Immature Thymocytes.
 
Newborn (1–6-d-old) mice and adult (7–8-wk-old) mice were
injected intraperitoneally with SEB (Sigma Chemical Co., St.
Louis, MO), anti-TCR mAb (H57-597), or ova 323–339 peptide
at the dose specified. At 20 (day 1), 44 (day 2), or 68 (day 3) h af-
ter injection, the mice were killed and cell surface markers of thy-
mocytes were analyzed.
 
In Vivo BrdU Labeling.
 
Mice (4–6 d) were intraperitoneally
injected with 0.3 mg of BrdU (Sigma Chemical Co.) in PBS
twice, at 20 and 12 h before the mice were killed (34, 35).
 
Culture Conditions.
 
As described previously, purified cells (2–3 
 
3
 
10
 
5
 
) were cultured in 0.2 ml of RPMI medium supplemented
with 5 
 
3 
 
10
 
2
 
5
 
 M 2-mercaptoethanol, 
 
l
 
-glutamine, and 10% FCS
in 96-well tissue culture plates coated with anti-TCR (H57-597)
 
6 
 
anti-CD28 (37.51) mAbs or medium alone for 20 h (27). For
in vitro negative selection of V
 
b
 
8
 
1
 
 HSA
 
hi
 
 CD4
 
1
 
 8
 
2
 
 cells, puri-
fied cells (2 
 
3 
 
10
 
5
 
) were cultured with splenic APCs (5 
 
3 
 
10
 
4
 
)
with or without SEB (10 
 
m
 
g/ml) in 96-well tissue culture plates
for 20 h. After harvesting, cells were stained and analyzed on a
FACSsort
 
Ò
 
 (Becton Dickinson).
 
Flow Cytometry Analysis.
 
For the in vivo studies, thymocytes
were incubated with FITC-conjugated anti-HSA mAb, PE-con-
jugated anti-CD8 (53-6.7), Cy5-conjugated anti-CD4 (GK1.5),
and biotinylated anti-V
 
b
 
8 (F23.1), anti-V
 
b
 
6 (RR4-7), or KJ1-26
mAbs, followed by TRI-COLOR conjugated streptavidin (Cal-
tag Lab., Burlingame, CA). For TUNEL (TdT-mediated dUTP-
biotin nick end labeling) staining of apoptotic cells, purified cells
were stained with PE-conjugated anti-V
 
b
 
8.1,2 (MR5-2) or anti-
V
 
b
 
6 mAbs, Cy-Chrome–conjugated anti-CD4 (H129.19), and
Cy5 conjugated-anti-HSA (J11D) mAbs, and then TUNEL
stained after cell fixation. TUNEL staining has been previously
described (36). For BrdU-labeled cells, purified CD8
 
2
 
 thy-
mocytes were stained with a mixture of biotinylated anti-V
 
b
 
8 or
anti-V
 
b
 
6 mAbs, Cy-chrome–conjugated anti-CD4 and Cy5-
conjugated anti-HSA mAbs, followed by PE-streptavidin (GIBCO
BRL). After staining for surface markers, cells were fixed with
ethanol and paraformaldehyde, treated with DNase, and then in-
cubated with FITC-conjugated anti-BrdU mAb as previously de-
scribed (35).
 
Results
 
Effects of SEB Injection in Adult versus Neonatal C3H
Mice.
 
To examine the effects of SEB on negative selec-
tion, SEB was injected intraperitoneally into normal C3H
versus Fas-deficient MRL
 
lpr/lpr
 
 mice. In these immunogenic
I-E
 
1
 
 strains, SEB is recognized by V
 
b
 
8
 
1
 
 T cells, especially
by CD4
 
1
 
 cells (29). In a previous study, injection of SEB
was reported to cause a twofold reduction in the propor-
tion of V
 
b
 
8
 
1
 
 cells in unseparated thymocytes 1 d later both
in normal and 
 
lpr/lpr
 
 mice (16); whether this finding was
V
 
b
 
 specific was unclear. The V
 
b-specific effects of SEB in-
jection on subsets of thymocytes in normal C3H mice is
discussed below. In all experiments a single dose of SEB
was injected.
At the level of CD41 8 1 double-positive (DP) thy-
mocytes, the effects of SEB injection in adult (10 wk) and
neonatal (4 d) C3H mice were quite different (Fig. 1). In
adult mice, injection of a large dose of SEB (200 mg)
caused pronounced destruction of DP cells and reduced the
total cellularity of the thymus by z80% at 2 d after injec-
tion; the elimination of DP cells was associated with a re-
ciprocal increase in single-positive (SP) CD41 8 2  and1429 Kishimoto et al.
CD42 81 cells. In neonatal mice, by contrast, a large dose
of SEB (50 mg) caused little or no reduction in the propor-
tion of DP cells and led to a smaller (20–50%) reduction in
total cellularity.
In contrast to DP cells, SEB injection had a clear Vb-
specific effect on CD41 82 SP cells, in both adult and neo-
natal mice (Fig. 1). At 2 d after injection, SEB injection
caused little or no alteration in the total proportion of SEB-
reactive Vb81 CD41 82 cells. However, when these cells
were typed for HSA expression, the Vb81 CD41 82 subset
showed a marked and selective reduction of semi-mature
HSAhi cells and a reciprocal increase in fully mature HSAlo
cells. In control PBS-injected mice, by contrast, the major-
ity of the Vb81 CD41 82 cells were HSAhi. The effect of
SEB injection appeared to be specific for Vb81 cells since
there was no change in the HSA phenotype of Vb61 cells.
SEB injection thus led to substantial elimination of HSAhi
Vb81 CD41 82 cells while causing apparent expansion of
HSAlo cells; these findings applied in both adult and neona-
tal mice. Unless stated otherwise, the experiments discussed
below refer to neonatal (4-d-old) C3H mice.
Kinetics. The above data apply to mice given SEB 2 d
before. Other time points are shown in Fig. 2. Gating on
unseparated CD41 82 cells (Fig. 2 A, column a) revealed
Figure 1. SEB-mediated neg-
ative selection of Vb81 CD41
82 thymocytes in adult and neo-
natal C3H mice. Adult (10-wk-
old) or newborn (4-d-old) mice
were injected intraperitoneally
with PBS or the indicated
amount of SEB, and thymuses
were harvested 2 d after injec-
tion; thymocyte suspensions
were four-color stained for CD4,
CD8, HSA, and Vb8 or Vb6
and were FACSÒ analyzed as de-
scribed in Materials and Meth-
ods. The following FACSÒ plots
are shown: CD4 versus CD8 on
all thymocytes (left); Vb8 and
Vb6 expression on gated CD41
82 cells (middle); and HSA ex-
pression on gated Vb81 CD41
82 and Vb61 CD41 8 2  cells
(right). The average number of
total thymocytes recovered from
each mouse is shown at the left.
The FACSÒ plots refer to thy-
mocytes from individual mice
and are representative of data
from 2 to 3 mice per group.
Figure 2. The kinetics of negative selection of Vb81 CD41 82 cells
induced by injection of SEB. Neonatal (4-d-old) C3H mice were in-
jected intraperitoneally with SEB (25 mg) at 1, 2, or 3 d before mice were
killed. Thymocytes from SEB-injected mice were then stained with
mAbs specific for Vb8 or Vb6, CD4, CD8, and HSA. (A) Left: Total cell
numbers (mean data from 5–8 mice per group) and CD4 versus CD8 ex-
pression (data from one representative mouse). Middle and right: (a) Vb8
expression on gated CD41 82 cells; (b) HSA expression on gated Vb81
CD41 82 cells; (c) Vb8 expression on gated HSAhi CD41 82 cells; (d)
Vb8 expression on gated HSAlo CD41 8 2 cells. (B) Total numbers of
CD41 8 2 thymocyte subsets per mouse recovered from SEB-injected
mice at the time points shown. Total numbers of Vb81 HSAhi versus
Vb81 HSAlo cells (left) and Vb61 HSAhi versus Vb61 HSAlo cells (right)
are shown. The data represent the mean values obtained from two differ-
ent experiments involving 5–8 mice per group.1430 A Role for Fas in Negative Selection of Thymocytes In Vivo
that the proportion of Vb81 cells was slightly reduced on
day 1 (20 h), increased on day 2 (44 h), and greatly reduced
on day 3 (68 h). Examining HSA expression on Vb81
CD41 8 2 cells (Fig. 2 A, column b) showed that HSAhi
cells were present on day 1, greatly reduced on day 2, but
again visible on day 3. When the data were expressed as to-
tal numbers of cells/thymus (Fig. 2 B, left), numbers of
Vb81 HSAhi CD41 82 cells were slightly reduced on day 1
and substantially reduced on days 2 and 3; levels of Vb61
cells, by contrast, remained largely unchanged (Fig. 2 B,
right). Essentially similar findings applied when Vb8 expres-
sion was examined on gated HSAhi CD41 82 cells (Fig. 2
A, column c). Thus, Vb81 cells in the HSAhi subset were
present at day 1 but markedly reduced on days 2 and 3.
This applied to both the proportion of cells (Fig. 2 A, col-
umn c) and total cell numbers (Fig. 2 B).
The data on Vb81 HSAlo CD41 8 2 cells were more
complex. Thus, total numbers of these fully mature cells
were moderately reduced on day 1, elevated on day 2, and
greatly reduced on day 3 (Fig. 2 B, left). Similar findings ap-
plied to the proportion of Vb81 cells in gated HSAlo CD41
82 cells (Fig. 2 A, column d).
Other Thymocyte Subsets. Since CD41 8 2 thymocytes
arise from CD41 81 precursors through progressive down-
regulation of CD8, FACS-gated CD41 82 thymocytes in-
clude a proportion of CD41 8lo cells, which are presumably
less mature than CD41 82 cells. The tolerance susceptibil-
ity of CD41 81 (CD41 8hi), CD41 8lo, and CD41 82 cells
to SEB is shown in Fig. 3 (note the “sharper” FACSÒ gate
for CD41 82 cells in Fig. 3 than in Figs. 1 and 2). At day 2
after SEB injection, it can be seen that the proportion of
Vb81 cells (the data in parentheses refer to mean values)
was considerably reduced in the CD41 8lo subset but mark-
edly elevated in the CD41 82 subset; proportions of Vb61
cells remained relatively unchanged. For CD41 8 hi cells,
Vb81 cells consisted mostly of TCRlo cells with very few
TCRhi cells. Significantly, SEB injection failed to deplete
either Vb8hi or Vb8lo cells from the CD41 8hi subset.
The above data suggest that, for the FACSÒ gates used,
SEB-induced elimination of thymocytes was restricted to
CD41 8 lo cells and did not include either CD41 8 hi or
CD41 82 cells. Here two points should be made. First, be-
fore injection, nearly all of the Vb81 CD41 8lo cells were
HSAhi (90%), attesting to their relative immaturity. How-
ever, after SEB injection the depleted population of Vb81
cells found on day 2 was enriched for HSAlo cells (50%),
implying that SEB selectively deleted the HSAhi Vb81 cells
and caused expansion of the small subset of Vb81 HSAlo
cells (data not shown). Second, HSAhi cells also accounted
for a considerable proportion of CD41 8 2 cells (60%).
However, at 2 d after SEB injection the expanded popula-
tion of Vb81 cells consisted almost entirely of HSAlo cells
(.90%) (data not shown).
Collectively, these data appear to indicate that the Vb81
cells eliminated by SEB injection were predominantly
HSAhi CD41 8lo cells. However, whether deletion also af-
fected the slightly more mature population of HSAhi cells
found in the CD41 82 subset could not be accurately es-
tablished because of the high levels of fully mature HSAlo
cells in the CD41 82 subset. To seek direct information on
this issue, we prepared purified populations of HSAhi
CD41 8 2 cells by positive panning (for HSA1 cells) and
negative selection with anti-CD8 mAb 1 C. This treat-
ment removed both CD41 8 hi and CD41 8 lo cells. The
HSAhi cells surviving this procedure were thus CD41 82
rather than CD41 8lo. The susceptibility of these purified
HSAhi CD41 82 cells to SEB-mediated deletion in vitro is
discussed below. For the in vivo experiments that follow, it
Figure 3. SEB-induced nega-
tive selection of CD41 8 hi,
CD41 8 lo, and CD41 8 2 thy-
mocytes. The data show Vb8
(bottom  left) and Vb6 (bottom right)
expression on gated CD41 8 hi,
CD41 8 lo, and CD41 8 2  thy-
mocytes from neonatal C3H
mice injected with PBS or SEB 1
or 2 d earlier. The FACSÒ gates
used to define CD4/CD8 ex-
pression are shown at the top.
For Vb expression, the percent-
ages shown refer to Vblo and Vbhi
cells for CD41 8 hi cells and to
Vbhi cells for CD41 8lo and CD41
82 cells. The data illustrated are
from a single representative from
each group; the numbers in pa-
rentheses refer to the mean val-
ues obtained from three mice per
group.1431 Kishimoto et al.
should be pointed out that the FACSÒ gate used to define
CD4/CD8 expression was the same as in Figs. 1 and 2
(rather than in Fig. 3); with this gate the cells defined as be-
ing CD41 8 2 consisted predominantly of CD41 8 2 cells
plus a small proportion of CD41 8lo cells (z30%). For con-
venience, the HSAhi cells in this mixed population will be
referred to hereafter as HSAhi CD41 82 cells.
Disappearance of HSAhi Cells Reflects Elimination. In inter-
preting the above data, a key issue is whether the disappear-
ance of HSAhi CD41 82 cells on day 2–3 after SEB injec-
tion (Fig. 2) simply reflected a switch to HSAlo cells. This
possibility is unlikely because previous studies showed that
culturing purified HSAhi CD41 82 cells with a combina-
tion of cross-linked anti-TCR 1 anti-CD28 mAb in vitro
caused many of the cells to undergo apoptosis (27) but
failed to downregulate HSA expression on the surviving
cells (our unpublished data). Similar findings applied when
purified HSAhi CD41 8 2 cells (depleted of 8lo cells; see
above) were cultured overnight with SEB plus spleen APC
in vitro (Fig. 4). As manifested by TUNEL staining, this
treatment induced substantial apoptosis of Vb81 HSAhi
cells (but not Vb61 cells) relative to cells cultured with
APCs without SEB (Fig. 4, A and B). However, there was
no reduction of HSA expression on the surviving (TUNEL2)
cells (Fig. 4 C). With mature HSAlo cells, exposure to SEB
failed to cause apoptosis of Vb81 cells (Fig. 4 D); since the
culture period was brief (20 h), expansion of Vb81 HSAlo
cells was not apparent. These findings applied to normal
cells stimulated with SEB in vitro. If the disappearance of
Vb81 HSAhi CD41 82 cells from the thymus between day
1 and 2 after SEB injection (Fig. 2) reflected death of these
cells (rather than a switch to HSAlo cells), onset of apoptosis
would be expected if the cells were harvested on day 1 after
in vivo SEB injection and then cultured in vitro without
further stimulus. This was indeed the case. Thus, when HSAhi
versus HSAlo CD41 8 2 thymocytes were purified from
mice given SEB 1 d before and cultured in vitro overnight
without APCs, there was significant apoptosis of Vb81
HSAhi cells but no apoptosis of Vb61 HSAhi cells (relative
to the background apoptosis in total HSAhi CD41 82 cells)
Figure 4. SEB-induced nega-
tive selection of CD41 8 2 thy-
mocytes in vitro. Purified HSAhi
or HSAlo CD41 8 2 thymocytes
from neonatal C3H mice were
cultured in vitro for 20 h with or
without SEB (10 mg/ml) in the
presence of splenic APCs. After
culture, cells were surface stained
for HSA, Vb8, and Vb6 expres-
sion; after washing, cells were
fixed and stained by TUNEL for
apoptotic cells. (A) Proportion of
TUNEL1 (apoptotic) cells in
gated Vb81 cells (left) and Vb61
cells (right) in HSAhi versus
HSAlo subsets; TUNEL staining
is plotted against forward scatter
(FSC). (B) Representation of the
data shown in A after subtraction
of the background values for ap-
optosis found for cells cultured
with APCs without SEB. (C)
HSA expression on viable
(TUNEL2) Vb81 cells (left) and
Vb61 cells (right) after culture
with APCs 6 SEB. (D) Proportion of Vb81 cells in the viable (TUNEL2) subsets of HSAhi versus HSAlo cells after culture with APCs 6 SEB. The data
shown are representative of three separate experiments.
Figure 5. Susceptibility of HSAhi versus HSAlo subsets of CD41 8 2
thymocytes to apoptosis in vitro after exposure to SEB in vivo. HSAhi
versus HSAlo CD41 8 2 thymocytes from neonatal C3H mice injected
with PBS or SEB (50 mg/mouse) 28 h earlier were purified by panning
and mAb 1 C (see Materials and Methods). The purified cells were cul-
tured in normal tissue culture medium in vitro for 20 h at 378C without
SEB or APCs and then stained for Vb8 or Vb6 followed by TUNEL
staining after fixation. Levels of apoptosis found for comparable cultured
populations of thymocytes prepared from uninjected control mice have
been subtracted from the data shown. The data represent the mean values
obtained from three separate experiments.1432 A Role for Fas in Negative Selection of Thymocytes In Vivo
(Fig. 5). For the HSAlo cells, there was slight apoptosis of
Vb81 cells and no apoptosis of Vb61 cells.
BrdU Incorporation. Collectively, these data suggest that
the disappearance of Vb81 HSAhi CD41 82 cells after SEB
injection reflected elimination of these cells rather than a
switch to HSAlo cells. For the HSAlo cells, the transient re-
duction in Vb81 cells at 1 day after SEB injection (Fig. 2)
suggested that a small subset of these cells was eliminated at
day 1. The minor degree of apoptosis seen when the cells
were cultured in vitro at 1 day after SEB injection (Fig. 5)
is consistent with this possibility. The expansion of Vb81
HSAlo cells at day 2 after SEB injection presumably indi-
cated proliferation of mature T cells to SEB.
To examine this possibility, groups of neonatal C3H
mice were injected with SEB and thymocytes were pre-
pared 1, 2, or 3 d later; BrdU (2 injections 12 h apart) was
administered for the last 20 h before preparation of thy-
mocytes. The data in Fig. 6 make three points. First, in
agreement with the known high turnover of CD41 82 cells
in the neonatal thymus (34), 20 h of exposure to BrdU la-
beled a high proportion of the Vb81 and Vb61 CD41 82
thymocytes in PBS-injected control mice; labeling was
higher for HSAhi cells than for HSAlo cells and, for Vb61
HSAhi cells of the SEB-injected groups, labeling declined
progressively as the 4-d-old mice aged over the 3-d period
studied. Second, relative to Vb61 cells, SEB injection
caused no obvious change in BrdU labeling of Vb81 cells
at 1 d after injection; this applied to both HSAhi and HSAlo
Vb81 cells. Third, labeling of Vb81 HSAlo cells increased
markedly at day 2 after SEB injection and then declined
abruptly on day 3. Labeling of Vb81 HSAhi cells, by con-
trast, was below normal on both day 2 and 3. Collectively,
these data indicate that SEB injection caused Vb81 HSAlo
cells to proliferate for a brief period (evident only on day 2)
and then disappear. This transient proliferative response did
not affect Vb81 HSAhi CD41 82 cells.
Dose of SEB and Role of Fas. As discussed earlier (see In-
troduction), apoptosis of purified HSAhi CD41 8 2 thy-
mocytes in response to combined TCR/CD28 ligation in
vitro was found to be Fas independent with a low concen-
tration of cross-linked anti-TCR mAb, but was completely
Fas dependent with a high dose of this mAb (27). This
finding is illustrated in Fig. 7, where it can be seen that
TCR/CD28 ligation of Fas-deficient B6lpr/lpr HSAhi CD41
82 cells in culture caused significant apoptosis at a low con-
centration of anti-TCR mAb (0.1 mg/ml) but not at a high
concentration (10 mg/ml). By contrast, apoptosis of HSAhi
CD41 8 2 cells from normal B6 mice was higher with a
high concentration of anti-TCR mAb than with a lower
concentration (Fig. 7). Similar findings applied when Fas
expression on normal B6 thymocytes was blocked with
Fas–Ig fusion protein (27).
To examine whether this role of Fas in negative selec-
tion also applied in vivo, we tested the effects of injecting
normal versus lpr/lpr neonatal mice with graded doses of
SEB. Based on the results considered above, the expecta-
tion was that a moderate-to-low dose of SEB would in-
duce negative selection of HSAhi Vb81 CD41 82 cells via a
Figure 6. BrdU incorporation by CD41 8 2 thymocyte subsets after
SEB injection. Neonatal C3H mice were injected with PBS or SEB and
killed 1, 2, or 3 d later (1 d later for PBS); starting at 20 h before death,
the mice received two intraperitoneal injections of BrdU 8 h apart (220 h
and 212 h). Purified CD82 cells (cells treated with anti-CD8 mAb 1 C)
were surface stained for Vb8 or Vb6, CD4, and CD8, then fixed and
stained for BrdU. The data show BrdU versus HSA expression on gated
Vb81 CD41 82 (left) and Vb61 CD41 82 (right) cells. The data are repre-
sentative of three separate experiments.
Figure 7. Relative sensitivity of
normal B6 and B6lpr/lpr HSAhi
CD41 8 2 thymocytes to SEB-
induced negative selection in
vitro. Purified HSAhi CD41 8 2
thymocytes prepared from adult
(6-wk-old) mice were cultured
in vitro for 20 h in wells coated
with a fixed concentration of
anti-CD28 mAb (10 mg/ml) plus
a low or high concentration of
anti-TCR mAb (0.1 mg/ml or
10 mg/ml). After culture, cells
were stained for TUNEL to de-
tect apoptotic cells. The data show percentage of apoptotic (TUNEL1)
cells after subtraction of the background levels for cells cultured alone.
The data represent the mean of four separate experiments.1433 Kishimoto et al.
Fas-independent pathway and thus cause cell deletion in
both normal and lpr/lpr mice. By contrast, with a high dose
of antigen, negative selection would be Fas dependent and
thus occur only in normal and not lpr/lpr mice.
In accordance with this prediction, injecting graded
doses of SEB into normal neonatal C3H or MRL mice in-
duced strong deletion of HSAhi Vb8 1 CD41 8 2 cells at
doses ranging from 1 to 100 mg SEB/mouse (Fig. 8 A and
data not shown). When injected into either MRLlpr/lpr or
C3Hlpr/lpr hosts, by contrast, SEB induced strong deletion at
up to 1 mg but caused little or no deletion at higher doses,
e.g., 100 mg. This difference between normal and lpr/lpr
mice was restricted to HSAhi cells and did not apply to con-
trol Vb61 cells (Fig. 8). Similar findings applied when SEB
was injected into adult mice (Fig. 8 B) and also when anti-
TCR mAb was injected into neonatal mice (Fig. 8 C). In
Figure 8. Negative selection of HSAhi CD41 82 thymocytes from C3H
versus MRLlpr/lpr mice injected with graded doses of SEB or anti-TCR mAb.
Thymocytes were prepared at 2 d after intraperitoneal injection of various
doses of SEB or anti-TCR mAb and stained. (A) Neonatal (4-d-old) C3H
mice injected with SEB. The data represent mean values from four separate
experiments with two to three mice per group. (B) Adult (7-wk-old) mice
injected with SEB. The data represent mean values from four separate ex-
periments with two mice/group. (C) Neonatal (4-d-old) mice injected with
anti-TCR mAb. The data show total numbers of CD41 82 subsets per thy-
mus. The data represent mean values from two separate experiments with
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each situation, a moderate dose of antigen induced strong
deletion of HSAhi CD41 82 cells in both normal and lpr/lpr
mice, whereas a high dose of antigen induced deletion only
in normal and not lpr/lpr mice.
Negative Selection in lpr/lpr TCR Transgenic Mice. To seek
further information on the role of Fas in negative selection,
we examined the effects of injecting specific peptide into
neonatal (4-d-old) normal versus Fas-deficient D011 TCR
transgenic mice; mature CD41 82 cells from this line are
strongly reactive to an ova peptide, ova 323–339, presented
by IAd (30).
The features of thymocytes from uninjected neonatal
D011 mice are shown in Fig. 9 A. Gating on the subset of
CD41 82 thymocytes revealed that nearly all of these cells
were clonotype-positive (Id1). In contrast to the discrete
subsets of HSAhi and HSAlo CD41 82 thymocytes found in
normal nontransgenic mice (Fig. 9 A, bottom, thick line), the
vast majority of CD41 8 2 thymocytes from D011 mice
were HSAhi (z90%) and therefore are potentially tolerance
susceptible. For this reason, detecting negative selection of
D011 thymocytes after ova peptide injection was relatively
easy and merely entailed examining CD4/CD8 expression
(rather than enumerating HSAhi CD41 82 cells).
The effects of injecting various doses of ova peptide into
neonatal D011 mice are shown in Fig. 9 B; thymocytes
were examined at day 2 after injection. For normal Fas1
D011 mice, injecting either a moderate dose (1 mg) or a
high dose (100 mg) of ova peptide caused a marked deple-
Figure 9. Negative selection
of HSAhi CD41 8 2 thymocytes
from neonatal (4-d-old) Fas1/2
versus Fas2/2 D011 TCR trans-
genic mice injected with graded
doses of ova 323–339 peptide.
Thymocytes were prepared at 2 d
after intraperitoneal injection of
peptide or PBS as a control and
stained for CD4, CD8, HSA,
and idiotypic (Id) TCR expres-
sion. (A) Phenotype of normal
(uninjected) Fas1/2 D011 thy-
mocytes showing CD4 versus
CD8 expression (top), TCR ex-
pression on CD41 8 2 cells de-
tected by the anticlonotypic
mAb KJ1-26 (middle), and HSA
expression on Id1 CD41 82 cells
(bottom); Id and HSA expression
on normal nontransgenic CD41
82 thymocytes is shown in the
heavy lines. (B) Representative
data on CD4 versus CD8 expres-
sion on thymocytes from Fas1/2
versus Fas2/2 D011 mice in-
jected with PBS and 1 or 100 mg
of ova peptide. (C) Total num-
bers of HSAhi CD41 8 2, HSAlo
CD41 8 2, and CD41 8 1 thy-
mocytes/mouse from Fas1/2
versus Fas2/2 D011 mice in-
jected with various doses of ova
peptide; the data represent mean
values from four separate experi-
ments with one to two mice per
group.1435 Kishimoto et al.
tion of (total) CD41 8 2 thymocytes. With Fas-deficient
D011lpr/lpr mice, by contrast, depletion of CD41 8 2 thy-
mocytes was apparent only with the lower dose of peptide;
with a high dose of peptide deletion of CD41 8 2 thy-
mocytes was minimal. Similar findings applied when the
data were expressed as total numbers of HSAhi CD41 82
thymocytes (Fig. 9 C, left). These data apply to thymocytes
examined at day 2 after injection. As for SEB, elimination
of HSAhi CD41 82 cells at day 1 after ova peptide injection
was quite limited (data not shown).
Injecting D011 mice with ova peptide caused little if any
expansion of the residual population of HSAlo CD41 82 thy-
mocytes. Indeed, especially in Fas1 D011 mice, peptide in-
jection appeared to delete both HSAhi and HSAlo CD41 82
cells (Fig. 9 C, middle). In interpreting this finding it should
be noted that, in contrast to normal thymocytes, D011 thy-
mocytes lacked a discrete subset of HSAlo CD41 82 cells
(Fig. 9 A, bottom): HSA expression was relatively homoge-
neous and the few HSAlo cells detected expressed interme-
diate levels of HSA and formed a continuum with the
HSAhi cells. Hence it is not surprising that the HSAlo cells
resembled HSAhi cells in being tolerance susceptible.
Unlike CD41 8 2 thymocytes, D011 CD41 8 1 thy-
mocytes were comparatively resistant to negative selection
(Fig. 9, B and C, right). Thus, even large doses of peptide
caused only minimal (30%) depletion of CD41 81 cells.
Discussion
The data in this paper make two main points. First, in-
jecting mice with antigen (either SEB or ova peptide)
caused marked antigen-specific elimination of the semi-
mature population of HSAhi CD41 82 thymocytes within
2 d. Second, based on studies with normal versus lpr/lpr
mice, the disappearance of these cells was Fas independent
at low doses of antigen but Fas dependent at high doses.
Before discussing the role of Fas, several features of the
elimination of HSAhi CD41 82 cells require comment.
The finding that the disappearance of Vb81 HSAhi
CD41 82 cells after SEB injection was associated with a re-
ciprocal increase in HSAlo cells raised the possibility that
the HSAhi cells were not deleted but simply switched to
HSAlo cells. This possibility is unlikely because exposing
HSAhi cells to SEB plus APCs in vitro caused rapid onset of
apoptosis of Vb81 cells and failed to reduce HSA expres-
sion on the surviving cells. In addition, when purified
HSAhi CD41 8 2 cells were prepared from SEB-injected
mice at 1 d after injection, the Vb81 subset of these cells
underwent apoptosis in vitro without further contact with
SEB, implying that the prior in vivo exposure to SEB had
already signaled the cells to die. In light of these findings,
the disappearance of Vb81 HSAhi CD41 82 cells after SEB
injection appeared to reflect clonal deletion of these cells
rather than differentiation into HSAlo cells. For D011 mice,
the paucity of HSAlo CD41 82 thymocytes in these mice
makes it most unlikely that the deletion of HSAhi cells re-
flected a switch to HSAlo cells. Thus, in this situation, pep-
tide injection caused extensive deletion of total CD41 82
thymocytes.
In tissue culture, deletion of HSAhi CD41 8 2 thymo-
cytes occurred quite rapidly. Thus, when HSAhi CD41 82
cells were exposed to SEB plus APCs in vitro, apoptosis of
Vb81 cells was clearly apparent after overnight culture;
whether these rapid kinetics also apply to ova peptide was
not tested. However, under in vivo conditions the elimina-
tion of HSAhi CD41 8 2 cells was limited on day 1 but
prominent at days 2 and 3 both for SEB and ova peptide.
Why the disappearance of HSAhi CD41 82 cells was de-
layed in vivo is unclear. One possibility is that the intra-
peritoneal route of injection impeded entry of antigen into
the bloodstream, and thus led to relatively slow accumula-
tion in the thymus. In support of this idea, injecting SEB
intravenously rather than intraperitoneally accelerated the
onset of Vb81 HSAhi cell elimination by z10 h (our un-
published data). For ova peptide, we have yet to examine
the effects of peptide injection beyond day 2. For SEB, the
maximal deletion of Vb81 HSAhi CD41 82 cells after in-
traperitoneal injection of SEB was at days 2 and 3. These
cells began to reappear in the thymus at about day 5 after
injection and reached normal levels by day 7 (our unpub-
lished data). The implication is that SEB was cleared from
the thymus within a few days, thus allowing rapid replace-
ment of the deleted cells by a new wave of HSAhi CD41 82
cells derived from DP precursors in the cortex.
With regard to the site of negative selection, many
workers consider that the deletion of immature T cells oc-
curs largely in the cortex (3). In favor of this idea, it is well
documented that injecting adult mice with antigen causes
massive apoptosis in the cortex (30). However, in this situ-
ation cortical apoptosis could be a reflection of stress in-
duced by stimulation of mature T cells in the periphery
(37). Such nonantigen-specific destruction of cortical thy-
mocytes is less of a problem in neonatal mice, which have
few peripheral T cells. Here, it is of interest that, for both
SEB and ova peptide, injecting neonatal hosts with antigen
caused marked elimination of HSAhi CD41 8 2 cells but
minimal deletion of CD41 8 1 cells. We considered the
possibility that injection of antigen caused deletion of a
small subset of CD41 81 cells, e.g., TCRhi cells. However,
gating on typical CD41 8 1 (8hi) cells after SEB injection
showed no detectable deletion of either Vb8lo or Vb8hi
cells (Fig. 3). Similarly, we failed to see deletion of either
TCRlo or TCRhi CD41 81 cells in D011 mice after ova
peptide injection (our unpublished data). Hence, for neo-
natal hosts and the two antigens studied here, negative se-
lection of typical cortical CD41 8 1 cells appeared to be
very limited. It should be emphasized that these data do not
exclude the possibility that the cortex is an important site of
negative selection in other systems. Nevertheless, it is nota-
ble that, even in adult mice, SEB-induced deletion of
Vb81 thymocytes is reported to be undetectable in mice
expressing MHC class II molecules only in the cortex (on
cortical epithelium) but not in the medulla (38).
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diate progeny of these cells, namely TCRhi HSAhi CD41
8lo cells, were strongly deleted after antigen injection (Fig.
3). Since the anatomical localization of CD41 8lo cells in
the thymus is unclear, it is possible that some of these cells
were deleted in the cortex before entering the medulla.
However, it is important to emphasize that, for both SEB
and ova peptide, the elimination of SP thymocytes applied
not only to HSAhi CD41 8 lo cells but also to the larger
population of HSAhi CD41 82 cells, which are presumably
slightly more mature than HSAhi CD41 8 lo cells. In fact
most of the experiments with SEB concerned CD41 8 2
cells rather than CD41 8lo cells. Similarly, for D011 mice,
injecting peptide deleted both HSAhi CD41 8lo and HSAhi
CD41 82 thymocytes (Fig. 9 B).
Since the vast majority of lymphoid cells in the medulla
are typical SP cells (39), most HSAhi CD41 82 thymocytes
are probably situated primarily in the medulla rather than
the cortex. In support of this idea, the medulla contains
considerable numbers of HSA1 cells in tissue sections (our
unpublished data), suggesting that many medullary T cells
are HSAhi. In addition, TUNEL staining has revealed that
SEB injection leads to increased numbers of apoptotic cells
in the medulla at day 2 after injection (our unpublished
data). For these reasons, it would seem highly likely that
the deletion of HSAhi CD41 82 cells takes place mainly in
the medulla (although the possibility that these cells initially
receive a death signal in the cortex cannot be excluded
[40]).
The elimination of HSAhi CD41 8 2 cells after antigen
injection did not appear to involve cell division. Thus, cell
cycle analysis of HSAhi CD41 82 cells has shown that the
rapid death of these cells after TCR ligation in vitro does
not involve entry into cell cycle (our unpublished data).
Likewise, the elimination of HSAhi CD41 82 cells in vivo
was not preceded by an increase in BrdU incorporation
(Fig. 6). This finding contrasts with fully-mature T cells
where TCR-mediated apoptosis (AICD) generally occurs
slowly and is preceded by an overt proliferative response
(41). Hence, for the fully mature subset of HSAlo CD41 82
thymocytes, we expected initial contact with SEB to be di-
rectly immunogenic for these cells. In line with this predic-
tion, SEB injection caused Vb81 HSAlo CD41 82 cells to
proliferate (incorporate BrdU) at 2 days after injection and
undergo considerable expansion. Surprisingly, however,
the expansion of Vb81 HSAlo cells was preceded by a tran-
sient decrease in numbers of these cells at day 1 after injec-
tion, probably via deletion. Why a proportion of these ma-
ture T cells succumbed to early deletion is unclear, although
a similar finding has been reported for peripheral T cells af-
ter SEB injection (10, 42). It is of interest that the expan-
sion of Vb81 HSAlo thymocytes was evident only at day 2
after injection and was followed by a marked reduction in
numbers of these cells on day 3; the disappearance of Vb81
HSAlo cells was also prominent on day 5 and levels of these
cells did not return to normal until after day 7, i.e., z2 d
later than for HSAhi cells (our unpublished data). At face
value the rapid elimination of proliferating Vb81 HSAlo
thymocytes after day 2 could reflect AICD and be the
counterpart of the rapid sequence of expansion followed by
deletion reported for peripheral Vb81 cells after SEB injec-
tion (10). However, whether the Vb81 HSAlo cells in the
thymus died in situ or migrated to the periphery is still un-
clear.
For SEB, it is worth noting that the near-complete elim-
ination of Vb81 cells, including mature HSAlo cells, seen at
days 3–5 after a single injection of SEB, is in line with the
original report that multiple injections of SEB caused
marked depletion of Vb81 SP thymocytes 8 d after the last
injection (29). Since earlier time points were not exam-
ined, the authors may have missed the prior expansion of
Vb81 cells reported here for HSAlo SP cells.
With regard to Fas, the main finding in this paper is that
in lpr/lpr mice the strong elimination of HSAhi CD41 82
thymocytes induced by SEB, ova peptide, and anti-TCR
mAb injection failed to occur when the dose of Ag/mAb
was increased to a high level. The implication therefore is
that negative selection is critically dependent upon Fas, but
only for antigens expressed at a high level. This finding
would seem to disagree with reports that injecting large
doses of specific peptide into TCR transgenic mice re-
duced the cellularity of the thymus by .10-fold, in both
normal and lpr/lpr mice (11, 25). But because adult mice
were used in these experiments, the possibility remains that
thymocytes were not eliminated via negative selection but
destroyed nonspecifically by stress (37). In another study,
giving multiple injections of SEB to neonatal mice over a
2-wk period caused equivalent deletion of Vb81 cells in
both normal and lpr/lpr mice (43). Since the effects of vary-
ing the dose of injected SEB was not tested, the relevance
of this finding to our data is unclear.
Much of the evidence that Fas is not involved in nega-
tive selection has come from the finding that lpr/lpr mice
show relatively normal thymocyte deletion in response to
endogenous SAgs and the male (HY) antigen (8, 12, 15,
17–20, 22–24). A corollary of the present data is that Fas is
irrelevant for negative selection to endogenous self-anti-
gens unless the concentration of these antigens in the thy-
mus is unusually high. Hence if endogenous SAgs and the
male antigen are expressed at only an “average” level
(equivalent to a low-to-moderate dose of SEB or ova pep-
tide), there is no discrepancy with the present data.
Although the range of self-antigens causing negative se-
lection is unknown, one can envisage that some antigens,
e.g., peptides derived from histones or other common in-
tracellular proteins, are expressed at a relatively high level.
Hence, based on our findings with SEB and ova peptide,
the elimination of T cells specific for these common self-
proteins might be Fas dependent and thus allow the reac-
tive T cells in lpr/lpr mice to escape central tolerance in-
duction in the thymus. Upon maturation and exit from the
thymus, these nontolerant T cells would continue to see
these antigens at a high concentration, but now in immu-
nogenic rather than tolerogenic form. Accordingly, the on-
set of lymphadenopathy and autoimmune disease in lpr/lpr1437 Kishimoto et al.
mice (8, 17) might be a reflection of an ongoing immune
response of nontolerant T cells directed to ubiquitous self-
antigens expressed at a high level.
This scenario rests on two assumptions. First, one has to
argue that the peripheral T cells in lpr/lpr mice are indeed
responding to self-antigens. Such a possibility has yet to be
proved, although the finding that all subsets of T cells in
lpr/lpr mice, including CD41 82 and CD42 81 cells, have
an abnormally high turnover in the periphery is consistent
with this idea (24, 44). The second assumption is that if T
cells in lpr/lpr mice are indeed autoreactive, the antigens
recognized by these cells are expressed at a high level rela-
tive to other antigens. Assessing this idea will hinge on de-
fining the peptide specificity of autoreactive T cells from
lpr/lpr mice.
As a final comment, it is important to emphasize that our
data suggest that Fas regulates negative selection at a rela-
tively late stage of thymocyte differentiation. The data are
thus in contrast with the report that Fas controls the early
onset of cortical apoptosis after peptide injection in TCR
transgenic models (26). Since these findings applied to adult
mice, cortical apoptosis may have been stress related. If so,
it is of interest that, for mature T cells, Fas ligand can act as
a costimulatory molecule (45), and that cytokine produc-
tion by lpr/lpr T cells in vitro is lower than for normal T
cells (11). Hence, stress-induced thymic atrophy after anti-
gen injection could be less marked in lpr/lpr mice.
In conclusion, the data in this paper indicate that clonal
elimination of antigen-specific T cells in the thymus after
antigen injection occurs at a relatively late stage of differen-
tiation and does not involve Fas when the dose of antigen
is kept to a low-to-moderate level. However, with a high
dose of antigen the presence of Fas becomes crucial for
negative selection. In light of these findings, the prior fail-
ure to find a clear role for Fas in central tolerance may re-
flect that the antigens studied were expressed at a relatively
low level.
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